Andrea Mega

Bolzano, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications

Effects of GLP1-RAs and SGLT2i on liver steatosis and fibrosis in MASLD with type 2 diabetes.

Effects of GLP1-RAs and SGLT2i on liver steatosis and fibrosis in MASLD with type 2 diabetes.

Journal: Minerva medica
Published: July 27, 2026

Age threshold and symptoms are useful for scheduling upper endoscopy in clinical practice.

Age threshold and symptoms are useful for scheduling upper endoscopy in clinical practice.

Journal: Internal and emergency medicine
Published: May 21, 2026

Immunotherapy in Hepatocellular Carcinoma with Portal Vein Tumour Thrombosis: From Poor Prognosis to Curative-Intent Strategies.

Immunotherapy in Hepatocellular Carcinoma with Portal Vein Tumour Thrombosis: From Poor Prognosis to Curative-Intent Strategies.

Journal: Cancers
Published: January 09, 2026

New Treatment Options for MASLD Patients with Type 2 Diabetes.

New Treatment Options for MASLD Patients with Type 2 Diabetes.

Journal: Life (Basel, Switzerland)
Published: December 19, 2025

Alcohol Plays a Detrimental Role in the Prognosis of Hepatocellular Carcinoma Related to Steatotic Liver Disease.

Alcohol Plays a Detrimental Role in the Prognosis of Hepatocellular Carcinoma Related to Steatotic Liver Disease.

Journal: Liver cancer
Published: November 11, 2025

Improvement of Liver Fibrosis in Patients with MASLD Undergoing Pioglitazone Treatment: An Update.

Improvement of Liver Fibrosis in Patients with MASLD Undergoing Pioglitazone Treatment: An Update.

Journal: Life (Basel, Switzerland)
Published: September 29, 2025

Salvage use of tacrolimus in steroid-refractory severe immune hepatitis from vulvar melanoma immunotherapy.

Salvage use of tacrolimus in steroid-refractory severe immune hepatitis from vulvar melanoma immunotherapy.

Journal: Clinics and research in hepatology and gastroenterology
Published: September 27, 2025

Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular Carcinoma.

Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular Carcinoma.

Journal: Liver cancer
Published: September 24, 2025

Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study.

Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study.

Journal: Alimentary pharmacology & therapeutics
Published: September 10, 2025

Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study.

Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study.

Journal: Liver cancer
Published: April 29, 2025

Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis.

Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis.

Journal: Cancers
Published: April 08, 2025

Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.

Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.

Journal: Digestive diseases and sciences
Published: March 02, 2025
Showing 1-12 of 61

Last Updated: 09/26/2026